Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Saturday, April 9, 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

In continuation of my update on Vandetanib,,,,,
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
https://www.med-chemist.com at 11:13 AM
Share

No comments:

Post a Comment

‹
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.